Biogen pulls its bid for Facet
Deadline passes as investors hold out for better offer
Biogen Idec Inc. came up empty-handed yesterday as it formally ended its three-month pursuit of Facet Biotech Corp. (Full article: 674 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
